in 19 asthmatic children , aged 2-6 years , the effect of six weeks ' treatment with inhaled budesonide or placebo on functional residual capacity ( frc -- helium dilution ) and bronchodilator responsiveness was assessed in a double blind , randomised crossover trial .
C0004096
asthmatic
C0054201
budesonide